ID

39632

Description

Safety and Efficacy of ANA598 Administered With Pegylated Interferon and Ribavirin in Genotype-1 Patients With Chronic HCV Infection; ODM derived from: https://clinicaltrials.gov/show/NCT01281423

Lien

https://clinicaltrials.gov/show/NCT01281423

Mots-clés

Versions (1)
  1. 06/02/2020 06/02/2020 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

6 février 2020

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Hepatitis C NCT01281423

Anglais

Eligibility Hepatitis C NCT01281423

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
documented chronic hepatitis c infection, genotype 1 at screening
Description

Chronic Hepatitis C Genotype

Type de données

boolean

Alias
UMLS CUI [1,1]
C0524910
UMLS CUI [1,2]
C1533728
treatment-naïve; no prior exposure to pegylated interferon, ribavirin, or experimental hcv therapy
Description

Therapy naive | Absence Exposure to PEGINTERFERON | Absence Exposure to Ribavirin | Absence Investigational Therapy Hepatitis C

Type de données

boolean

Alias
UMLS CUI [1]
C0919936
UMLS CUI [2,1]
C0332197
UMLS CUI [2,2]
C0332157
UMLS CUI [2,3]
C0982327
UMLS CUI [3,1]
C0332197
UMLS CUI [3,2]
C0332157
UMLS CUI [3,3]
C0035525
UMLS CUI [4,1]
C0332197
UMLS CUI [4,2]
C0949266
UMLS CUI [4,3]
C0019196
treatment-experienced patients including partial responders, prior relapse, prior viral breakthrough, and null responders; prior treatment with current standard of care (pegylated interferon alfa and ribavirin)
Description

Therapeutic procedure Experience | Therapy partial responder | Recurrent disease | Viral Breakthrough | Null responder | Standard of Care Previous | pegylated interferon alfa | Ribavirin

Type de données

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0596545
UMLS CUI [2]
C4285679
UMLS CUI [3]
C0277556
UMLS CUI [4]
C4053869
UMLS CUI [5,1]
C0456148
UMLS CUI [5,2]
C0919876
UMLS CUI [6,1]
C2936643
UMLS CUI [6,2]
C0205156
UMLS CUI [7]
C0907160
UMLS CUI [8]
C0035525
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
female patients who are pregnant or breast feeding
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
infection with non-genotype 1 hcv
Description

Hepatitis C | Exception Hepatitis C virus genotype determination

Type de données

boolean

Alias
UMLS CUI [1]
C0019196
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C1533728
for treatment-naïve patients: any previous treatment for hcv infection
Description

Patients Therapy naive | Prior Therapy Hepatitis C

Type de données

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0919936
UMLS CUI [2,1]
C1514463
UMLS CUI [2,2]
C0019196
for treatment-experienced patients: previous treatment with any direct-acting antivirals for hcv infection
Description

Patients Therapeutic procedure Experience | Prior Therapy DIRECT ACTING ANTIVIRALS Hepatitis C

Type de données

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0596545
UMLS CUI [2,1]
C1514463
UMLS CUI [2,2]
C3653501
UMLS CUI [2,3]
C0019196
known hiv or hbv co-infection
Description

HIV coinfection | HBV coinfection

Type de données

boolean

Alias
UMLS CUI [1]
C4062778
UMLS CUI [2]
C2242656
any medical contraindications to peg-inf or rbv therapy
Description

Medical contraindication PEGINTERFERON | Medical contraindication Ribavirin

Type de données

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0982327
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0035525
history of any other known cause of liver disease
Description

Liver disease Cause Other

Type de données

boolean

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C0015127
UMLS CUI [1,3]
C0205394
Retour au début de la page

Similar models

Eligibility Hepatitis C NCT01281423

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Chronic Hepatitis C Genotype
Item
documented chronic hepatitis c infection, genotype 1 at screening
boolean
C0524910 (UMLS CUI [1,1])
C1533728 (UMLS CUI [1,2])
Therapy naive | Absence Exposure to PEGINTERFERON | Absence Exposure to Ribavirin | Absence Investigational Therapy Hepatitis C
Item
treatment-naïve; no prior exposure to pegylated interferon, ribavirin, or experimental hcv therapy
boolean
C0919936 (UMLS CUI [1])
C0332197 (UMLS CUI [2,1])
C0332157 (UMLS CUI [2,2])
C0982327 (UMLS CUI [2,3])
C0332197 (UMLS CUI [3,1])
C0332157 (UMLS CUI [3,2])
C0035525 (UMLS CUI [3,3])
C0332197 (UMLS CUI [4,1])
C0949266 (UMLS CUI [4,2])
C0019196 (UMLS CUI [4,3])
Therapeutic procedure Experience | Therapy partial responder | Recurrent disease | Viral Breakthrough | Null responder | Standard of Care Previous | pegylated interferon alfa | Ribavirin
Item
treatment-experienced patients including partial responders, prior relapse, prior viral breakthrough, and null responders; prior treatment with current standard of care (pegylated interferon alfa and ribavirin)
boolean
C0087111 (UMLS CUI [1,1])
C0596545 (UMLS CUI [1,2])
C4285679 (UMLS CUI [2])
C0277556 (UMLS CUI [3])
C4053869 (UMLS CUI [4])
C0456148 (UMLS CUI [5,1])
C0919876 (UMLS CUI [5,2])
C2936643 (UMLS CUI [6,1])
C0205156 (UMLS CUI [6,2])
C0907160 (UMLS CUI [7])
C0035525 (UMLS CUI [8])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
female patients who are pregnant or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Hepatitis C | Exception Hepatitis C virus genotype determination
Item
infection with non-genotype 1 hcv
boolean
C0019196 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C1533728 (UMLS CUI [2,2])
Patients Therapy naive | Prior Therapy Hepatitis C
Item
for treatment-naïve patients: any previous treatment for hcv infection
boolean
C0030705 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
C1514463 (UMLS CUI [2,1])
C0019196 (UMLS CUI [2,2])
Patients Therapeutic procedure Experience | Prior Therapy DIRECT ACTING ANTIVIRALS Hepatitis C
Item
for treatment-experienced patients: previous treatment with any direct-acting antivirals for hcv infection
boolean
C0030705 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0596545 (UMLS CUI [1,3])
C1514463 (UMLS CUI [2,1])
C3653501 (UMLS CUI [2,2])
C0019196 (UMLS CUI [2,3])
HIV coinfection | HBV coinfection
Item
known hiv or hbv co-infection
boolean
C4062778 (UMLS CUI [1])
C2242656 (UMLS CUI [2])
Medical contraindication PEGINTERFERON | Medical contraindication Ribavirin
Item
any medical contraindications to peg-inf or rbv therapy
boolean
C1301624 (UMLS CUI [1,1])
C0982327 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0035525 (UMLS CUI [2,2])
Liver disease Cause Other
Item
history of any other known cause of liver disease
boolean
C0023895 (UMLS CUI [1,1])
C0015127 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial